SHANE KELEHAN: Open Payments
NPI 1902237936 · MARSHALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 47 payments from 14 companies in 2025. Trend: 2023 $1,353 · 2024 $1,087 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $222 |
| Novo Nordisk Inc | 12 | $205 |
| Lilly USA, LLC | 9 | $128 |
| ABBVIE INC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Exact Sciences Corporation | 3 | $51 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: BREZTRI, MOUNJARO, Rybelsus, Ozempic, JARDIANCE, Wegovy, Kerendia, Quviviq.
Industry payments across TX — which companies pay providers there.
